News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,683 Results
Type
Article (5945)
Company Profile (46)
Press Release (227692)
Multimedia
Podcasts (3)
Webinars (5)
Section
Business (66981)
Career Advice (383)
Deals (14441)
Drug Delivery (25)
Drug Development (18379)
Employer Resources (41)
FDA (6286)
Job Trends (5640)
News (108592)
Policy (8806)
Tag
Academia (674)
Accelerated approval (1)
Adcomms (1)
Allergies (29)
Alliances (21683)
ALS (33)
Alzheimer's disease (400)
Antibody-drug conjugate (ADC) (27)
Approvals (6321)
Artificial intelligence (175)
Autoimmune disease (8)
Automation (15)
Bankruptcy (122)
Best Places to Work (5175)
BIOSECURE Act (3)
Biosimilars (30)
Biotechnology (35)
Bladder cancer (36)
Brain cancer (10)
Breast cancer (95)
Cancer (777)
Cardiovascular disease (40)
Career advice (340)
Career pathing (10)
CAR-T (41)
Cell therapy (131)
Cervical cancer (9)
Clinical research (15612)
Collaboration (450)
Compensation (87)
Complete response letters (3)
COVID-19 (704)
CRISPR (19)
C-suite (81)
Cystic fibrosis (15)
Data (829)
Decentralized trials (2)
Denatured (2)
Depression (12)
Diabetes (76)
Diagnostics (3501)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (17)
Drug discovery (47)
Drug pricing (26)
Drug shortages (3)
Duchenne muscular dystrophy (12)
Earnings (24829)
Editorial (6)
Employer resources (38)
Events (30346)
Executive appointments (324)
FDA (6910)
Funding (319)
Gene editing (36)
Generative AI (14)
Gene therapy (82)
GLP-1 (145)
Government (969)
Grass and pollen (1)
Guidances (72)
Healthcare (7055)
Huntington's disease (1)
IgA nephropathy (7)
Immunology and inflammation (21)
Indications (14)
Infectious disease (751)
Inflammatory bowel disease (43)
Inflation Reduction Act (4)
Influenza (21)
Intellectual property (43)
Interviews (60)
IPO (6154)
IRA (8)
Job creations (683)
Job search strategy (268)
Kidney cancer (4)
Labor market (5)
Layoffs (65)
Leadership (11)
Legal (1745)
Liver cancer (23)
Lung cancer (113)
Lymphoma (54)
Machine learning (5)
Management (17)
Manufacturing (164)
MASH (28)
Medical device (7752)
Medtech (7755)
Mergers & acquisitions (8638)
Metabolic disorders (171)
Multiple sclerosis (29)
NASH (3)
Neurodegenerative disease (20)
Neuropsychiatric disorders (3)
Neuroscience (559)
NextGen: Class of 2025 (2593)
Non-profit (1157)
Now hiring (4)
Obesity (71)
Opinion (56)
Ovarian cancer (27)
Pain (42)
Pancreatic cancer (27)
Parkinson's disease (43)
Partnered (12)
Patents (114)
Patient recruitment (40)
Peanut (17)
People (17514)
Pharmaceutical (10)
Pharmacy benefit managers (3)
Phase I (4085)
Phase II (6722)
Phase III (6035)
Pipeline (522)
Policy (25)
Postmarket research (495)
Preclinical (1620)
Press Release (19)
Prostate cancer (35)
Psychedelics (5)
Radiopharmaceuticals (73)
Rare diseases (96)
Real estate (2007)
Recruiting (12)
Regulatory (6770)
Reports (15)
Research institute (680)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (1)
RSV (8)
Schizophrenia (16)
Series A (48)
Series B (38)
Service/supplier (8)
Sickle cell disease (16)
Special edition (2)
Spinal muscular atrophy (44)
Sponsored (16)
Startups (938)
State (1)
Supply chain (39)
Tariffs (3)
The Weekly (1)
Vaccines (158)
Venture capitalists (7)
Weight loss (34)
Women's health (16)
Worklife (7)
Date
Last 7 days (326)
Last 30 days (1116)
Last 365 days (12928)
2025 (4699)
2024 (14010)
2023 (15666)
2022 (21896)
2021 (23253)
2020 (22700)
2019 (19513)
2018 (14074)
2017 (11851)
2016 (10620)
2015 (11789)
2014 (8496)
2013 (7073)
2012 (7605)
2011 (7485)
2010 (6353)
Location
Africa (181)
Alabama (15)
Alaska (2)
Arizona (61)
Arkansas (4)
Asia (12271)
Australia (1637)
California (2350)
Canada (917)
China (181)
Colorado (116)
Connecticut (94)
Delaware (75)
Europe (30242)
Florida (417)
Georgia (113)
Idaho (42)
Illinois (257)
India (11)
Indiana (208)
Iowa (7)
Japan (86)
Kansas (29)
Kentucky (7)
Louisiana (5)
Maine (26)
Maryland (278)
Massachusetts (1445)
Michigan (177)
Minnesota (223)
Mississippi (2)
Missouri (48)
Montana (24)
Nebraska (12)
Nevada (27)
New Hampshire (43)
New Jersey (669)
New Mexico (18)
New York (792)
North Carolina (502)
North Dakota (8)
Northern California (1007)
Ohio (100)
Oklahoma (6)
Oregon (13)
Pennsylvania (500)
Puerto Rico (6)
Rhode Island (16)
South America (385)
South Carolina (21)
South Dakota (1)
Southern California (845)
Tennessee (42)
Texas (401)
United States (9352)
Utah (67)
Virginia (50)
Washington D.C. (18)
Washington State (236)
West Virginia (2)
Wisconsin (51)
233,683 Results for "intent solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
March 26, 2025
·
6 min read
Press Releases
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
April 9, 2025
·
6 min read
Press Releases
Optimind Pharma Enters into Letter of Intent with Monjin to Acquire AI Business
March 25, 2025
·
4 min read
Press Releases
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
March 21, 2025
·
7 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business
March 12, 2025
·
12 min read
Press Releases
Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC
May 7, 2025
·
4 min read
Press Releases
Innate Pharma Regains Its Rights on CD123 Targeting ANKET® and Announces Sanofi’s Intention to Make a Strategic Investment in the Company
April 23, 2025
·
7 min read
Press Releases
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
May 1, 2025
·
3 min read
Press Releases
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
March 31, 2025
·
3 min read
1 of 23,369
Next
